Stocklytics Platform
Asset logo for symbol CASI
CASI Pharmaceuticals
CASI55
$1.92arrow_drop_up1.59%$0.03
Penny Stock
Asset logo for symbol CASI
CASI55

$1.92

arrow_drop_up1.59%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

CASI Pharmaceuticals (CASI) Stocklytics Forecast

CASI Pharmaceuticals Inc. (CASI) is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat cancer and other diseases. The company's pipeline includes a range of promising drug candidates that are targeting unmet medical needs in various therapeutic areas. With its strong emphasis on research and development, CASI is well positioned to leverage the latest advancements in medical science to deliver effective and safe treatments to patients worldwide.
When it comes to the stock price prediction for CASI Pharmaceuticals Inc, analysts and AI algorithms are both optimistic about its future performance. Based on historical data and market trends, the consensus forecast suggests that CASI stock has the potential for significant growth in the coming years. In particular, market experts predict that CASI's stock price will experience substantial gains by the year 2023. This projection is supported by machine learning algorithms that analyze various factors, such as financial performance, industry trends, and market sentiment.
add CASI Pharmaceuticals to watchlist

Keep an eye on CASI Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for CASI Pharmaceuticals (CASI) stock?

Analysts have set a target price of $9.23 for CASI Pharmaceuticals (CASI), based on forecasts from 11 analysts. The predicted price range extends from a high of $21 to a low of $3. This represents a potential increase of up to 993.75% and a decrease of 56.25% from the current price of $1.92. These forecasts are as of 2015 Jun 23.
help

What are the analyst ratings for CASI Pharmaceuticals (CASI) stock?

The analyst ratings for CASI Pharmaceuticals (CASI) are distributed as follows: 1 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering CASI Pharmaceuticals .
help

What is the AI price prediction for CASI Pharmaceuticals (CASI) stock?

At present, there is no AI or machine-learning-based price prediction available for CASI Pharmaceuticals (CASI) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level